Form 4: Shattuck Labs CMO Disposes Shares for Tax Withholding

Shattuck Labs' Chief Medical Officer, Arundathy N. Pandite, disposed of 3,195 shares of common stock for tax withholding purposes.

Summary

• Arundathy N. Pandite, Chief Medical Officer of Shattuck Labs, Inc. (STTK), reported a disposition of common stock.
• The transaction involved 3,195 shares of common stock disposed of at a price of $4.15 per share.
• The disposition was made to satisfy tax withholding obligations, indicated by transaction code 'F'.
• Following this transaction, Ms. Pandite beneficially owns 196,219 shares of Shattuck Labs common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary disposition of shares for tax withholding, which is a neutral event with no direct positive or negative implications for the company's operational performance or strategic direction.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a routine insider transaction for tax withholding purposes and does not provide specific insights into broader industry trends or competitive landscape.

Related Party Transactions

• The transaction involves an insider (Chief Medical Officer) disposing of company stock, which is a related party transaction, specifically for tax withholding purposes.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction by an officer for tax purposes, not a discretionary sale indicating a change in confidence.
• Employees: No direct impact on employees.

Key Dates

Keywords

Shattuck Labs, STTK, Form 4, Insider Transaction, Stock Disposition, Chief Medical Officer, Tax Withholding